Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
about
Functional and molecular image guidance in radiotherapy treatment planning optimization.Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.PET/CT Imaging and Radioimmunotherapy of Prostate CancerFunctional imaging for prostate cancer: therapeutic implications.Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developmentsApplication of metabolic PET imaging in radiation oncology.PET and PET/CT in radiation treatment planning for prostate cancer.Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy.The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging.Current standards and future directions for prostate cancer radiation therapy.Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer.Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate CancerProstate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.Dimeric [68Ga]DOTA-RGD Peptide Targeting αvβ3 Integrin Reveals Extracellular Matrix Alterations after Myocardial Infarction
P2860
Q34706820-75FA42F4-71D1-48C9-9FE6-308222FDEFEEQ35515150-488C2DDB-9953-4C7A-8CFE-C83318B85974Q36085426-0EB311C6-DD0E-423B-BC65-BFAEE30FE885Q36128629-45D85120-41F4-417C-A486-0DD1DB2ED083Q36325435-4665C306-A80E-4EE5-A5FB-B14890207014Q37580845-C42CE7E2-103E-404A-AB3B-DA8AF5204092Q37909361-9DDC2123-111A-4554-9F0B-6C26975E8C28Q38098124-DD7BD2C0-A1E9-49E2-913C-B98748E3361AQ38098441-2AF9BC25-89F9-4999-AC91-0D0DF4A3F9ADQ38722286-A8744836-C246-4C2B-ACB3-EF3A5C4ECAC4Q38851017-E8D25CAF-5F63-4600-A923-5A8FE3B3F296Q39499604-B6FDC184-2A7B-4701-B6EB-9C6D96AABB33Q39508939-F7C292C8-C549-4ECE-B697-D8C4A0815DBCQ39532552-30A9718D-731D-4C7B-8C29-A22674897653Q41895037-E248BB36-EB21-4386-B969-0EAD7F4B479EQ42841450-0C42D862-45FB-481E-A0FC-B0CFC3BD1812Q43202790-F082AAF7-F624-4802-B202-8057DCC2754AQ57621665-08CA7371-2F73-4569-8A4C-948F1582C366
P2860
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
@en
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
@nl
type
label
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
@en
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
@nl
prefLabel
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
@en
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
@nl
P2093
P1476
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer
@en
P2093
Eveliina Arponen
Marko Seppänen
Paula Lindholm
P304
P356
10.1016/J.RADONC.2009.08.010
P577
2009-09-18T00:00:00Z